← Leaderboards
Marin Leigh Schweizer
University Of Wisconsin-Madison
$4,424,967
Attributed
$6,500,881
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,151,828 · 1
AHRQ$2,349,053 · 1
VA$0 · 3
By mechanism
KL2$4,151,828 · 1
R01$2,349,053 · 1
I01$0 · 2
IK2$0 · 1
Top collaborators
- Kalpana Gupta4 shared
- Bo Liu4 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Susan C Pitt$2,329,214
- Carolyn Timberlake Thorpe$2,721,576
- Jessica Kelliher$201,118
- Heather B Neuman$3,392,239
Others in their field
Top investigators on “Guidelines”
- Judith S. Currier · University Of California Los Angeles$272,240,505
- Lawrence Corey · Fred Hutchinson Cancer Center$207,121,712
- Michelle Vargas · Ppd Development Lp$176,419,297
- Norman Wolmark · Nsabp Foundation, Inc.$173,683,613
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$172,075,623
- Daniel R Kuritzkes · Brigham And Women'S Hospital$135,335,138
Research focus
GuidelinesInnovationLifePositioning AttributeAntibiotic ResistanceCommunicable DiseasesDatabasesVeteransInfectionHospitalsProgramsAntibioticsAreaSuccessAntimicrobialAdvisory CommitteesAdverse EventInterviewOperative Surgical ProceduresFrightFundingDesignFutureData Warehouse
Grant awards (19)
Institutional Career Development Core$1,037,957
KL2 · FY2025 · TR · contact PI
Institutional Career Development Core$1,037,957
KL2 · FY2024 · TR · contact PI
De-Implementing Testing and Treating of Urine Cultures in Asymptomatic Patients$0
I01 · FY2024 · VA
Institutional Career Development Core$1,037,957
KL2 · FY2023 · TR · contact PI
Povidone-iodine to Stop Access-related Infections and Transmission of Staphylococcus aureus (PAINTS)$350,021
R01 · FY2023 · HS · contact PI
Chronic Antibiotic Suppression after Prosthetic Joint Infection: A Target for De-implementation$0
I01 · FY2023 · VA · contact PI
De-Implementing Testing and Treating of Urine Cultures in Asymptomatic Patients$0
I01 · FY2023 · VA
Institutional Career Development Core$1,037,957
KL2 · FY2022 · TR · contact PI
Povidone-iodine to Stop Access-related Infections and Transmission of Staphylococcus aureus (PAINTS)$276,761
R01 · FY2022 · HS · contact PI
Povidone-iodine to Stop Access-related Infections and Transmission of Staphylococcus aureus (PAINTS)$223,172
R01 · FY2022 · HS · contact PI
De-Implementing Testing and Treating of Urine Cultures in Asymptomatic Patients$0
I01 · FY2022 · VA
Povidone-iodine to Stop Access-related Infections and Transmission of Staphylococcus aureus (PAINTS)$499,445
R01 · FY2021 · HS · contact PI
Chronic Antibiotic Suppression after Prosthetic Joint Infection: A Target for De-implementation$0
I01 · FY2021 · VA · contact PI
Povidone-iodine to Stop Access-related Infections and Transmission of Staphylococcus aureus (PAINTS)$499,999
R01 · FY2020 · HS · contact PI
Chronic Antibiotic Suppression after Prosthetic Joint Infection: A Target for De-implementation$0
I01 · FY2020 · VA · contact PI
De-Implementing Testing and Treating of Urine Cultures in Asymptomatic Patients$0
I01 · FY2020 · VA
Povidone-iodine to Stop Access-related Infections and Transmission of Staphylococcus aureus (PAINTS)$499,655
R01 · FY2019 · HS · contact PI
Chronic Antibiotic Suppression after Prosthetic Joint Infection: A Target for De-implementation$0
I01 · FY2018 · VA · contact PI
Comparative Effectiveness of Strategies to Control S. aureus Infections$0
IK2 · FY2014 · VA · contact PI